Executive Summary:
The Global Carcinoembryonic Antigen (CEA) Market is a vital segment within the cancer diagnostics and tumor marker industry. CEA is a glycoprotein primarily used as a non-specific serum biomarker to monitor treatment efficacy, detect disease recurrence, and provide prognostic information for several cancers, most notably colorectal cancer (CRC).
The market is...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)